Finally, as growing evidence suggests the interactive roles of NFκB signaling and inflammation in tumorigenesis [57], more IHC tests of biomarkers associated with immune cells, such as tumor-associated macrophage, and an in vivo investigation would help clarify the association of radiation on the tumor microenvironment and NFκB activation. The gene discussed is NFKB1; the disease is neoplasm.